Universitätsklinikum Würzburg

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022. (2022) Thill M, Lueftner D, Kolberg-Liedtke C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, et al. Journal article, Review article Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer. (2022) Aktas B, Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2021 Part 4 - Prevention and Early Stages. (2022) Thomssen C, Fehm TN, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, et al. Journal article, Review article Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer. (2022) Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, Kolberg-Liedtke C, Kolberg HC, et al. Journal article, Review article Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer. (2022) Welslau M, Mueller V, Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer. (2022) Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, Janni W, et al. Journal article, Review article Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience (2022) Dreger P, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner E, Wulf G, et al. Journal article Value of a web-based pediatric drug information system to prevent serious adverse drug reactions in child and adolescent psychiatry (2022) Fekete S, Kulpok C, Taurines R, Egberts K, Geissler J, Gerlach M, Makosi DM, et al. Journal article Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry (2022) Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schaefer-Eckart K, Steffen B, Sauer T, et al. Journal article